(The Revised) Lay Person’s Guide to Medicines, LOCOST, Baroda, India, 2006

This is a book on the political economy of the pharmaceutical industry in India. This publication addresses pricing and related issues of the drug industry in India. It draws upon the experiences and insights of people, who have, over the past 25 years,  consistently engaged the government to ensure access to less expensive, safer, and more rational medicines. CLICK HERE to access the book.

The detailed medicine information which is part of the hard copy is not available here. Contact S. Srinivasan (“Chinu”), Co-author and Editor at for more details.

For more resources, please visit

Impoverishing the Poor:Pharmaceuticals and Drug Pricing in India

The immediate context of the booklet was the case pending in the Supreme Court in which LOCOST, Jana Swasthya Sahyog (JSS), All India Drug Action Network (AIDAN) and the Medico Friend Circle (mfc) were co-petitioners. We had filed a series of affidavits in the matter questioning the wisdom of the criteria for drug price control in Pharmaceutical Policy 2002 (PP 02). It was our submission that the policy would increase the price of medicines and therefore have a long-term effect, for the worse, on the health of people, especially poor people. The related SC order of 10/3/2003 said, “… We direct that the petitioner shall consider and formulate appropriate criteria for ensuring essential and life saving drugs not to fall out of price control…” Read the book HERE

‘Medicines for All’, the Pharma Industry and the Indian State

Srinivasan S

When we consider that expenditure on medicines in India accounts for 50% to 80% of treatment costs, India’s pharmaceutical success has clearly not translated into availability or affordability of medicines for all. As part of Universal Access to Healthcare, good quality healthcare should be accessible, affordable, and available to all in need. Providing quality medicines to all – free at the point of service – in all our public facilities is an achievable task. This article estimates the cost of providing free and quality medicines at all levels of public healthcare and offers suggestions
on how this can be done.

Source: Economic & Political Weekly, June 11, 2011 Vol XLVI No 24, 43-50


International Organisations

World Health Organization

WHO – Essential Drug & Medicine Policy

International Network for Rational Use of Drugs

Management Sciences for Health

Medecines Sans Frontieres

International Dispensary Association

WHO South East Asia Regional Office

Health Action International

Health Action International – Asia Pacific


Journal of Indian Medical Association

British National Formulary

British Medical Journal

Indian Journal of Pharmacology

The National Medical Journal of India

The Essential Drug Monitor


Indian Council of Medical Research

Central Drug Standard Control Organization

Delhi Society for Promotion of Rational Drug Use

Voluntary Health Association

Catholic Health Association

Christian Medical Association

Essential drugs


No Free Lunch


Uppsala Monitoring Center

World Medical Association:

Healthy Skepticism:

People’s Health Movement
International Society of Drug Bulletins (ISDB)

Medico Friends Circle


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s